India's TB Deaths Fall 38% Since 2015: What the WHO Global TB Report 2026 Shows
The Union Ministry of Health and Family Welfare said on 12 November 2026 that India's estimated tuberculosis (TB) deaths fell by 38% between 2015 and 2025. The figure comes from the World Health Organization's (WHO) Global Tuberculosis Report 2026.
India's TB death rate fell from about 28 to 18 deaths per lakh people in this period. The fall across the whole world was 35%, so India did a little better than the global average.
The treatment success rate for drug-susceptible TB (normal TB that ordinary medicines can kill) reached 94%. Worldwide, the figure was 90%.
Under the TB Mukt Bharat Abhiyaan campaign (7 December 2024 to 8 November 2026), over 25 crore people were screened and 48.64 lakh TB cases were found. Of these, 14.97 lakh people had no symptoms at all (asymptomatic). They were found only because of active screening with chest X-rays and rapid tests.
The Ministry credited early detection, AI-enabled hand-held X-rays, rapid molecular tests, quick start of treatment and nutrition support.
Drug-resistant TB remains the big challenge. Worldwide, about 3.7 lakh people got rifampicin-resistant TB in 2025, and only about 42% of them got treatment, leaving a large treatment gap.
National Tuberculosis Elimination Programme (NTEP)
The National Tuberculosis Elimination Programme (NTEP) is the Government of India's main programme to find, treat and prevent TB. It gives free tests, free medicines and money for food to every TB patient, in both government and private hospitals. It is run by the Union Ministry of Health and Family Welfare through its Central TB Division. It was called the Revised National TB Control Programme (RNTCP) until it was renamed NTEP on 1 January 2020.
The 38% fall in TB deaths is the result of NTEP's tools: door-to-door screening, hand-held X-rays, rapid molecular tests and food support. The 14.97 lakh asymptomatic cases found in the campaign show why active screening matters: these people would never have walked into a clinic on their own, yet they could still spread the disease.
End TB Strategy (WHO): The Global Plan to End Tuberculosis by 2035
The End TB Strategy is WHO's global plan to end the TB epidemic. It was approved by the World Health Assembly in May 2014 and covers the years 2016 to 2035. It sets targets using 2015 as the starting year, which is why progress in TB is always measured "since 2015". WHO checks the world's progress every year in its Global Tuberculosis Report.
India's 38% fall in deaths beats the 35% global figure, but it is still well short of the End TB Strategy's 2025 milestone of a 75% fall. This gap is why the report is read as real progress, but not yet success.
Drug-Resistant Tuberculosis (DR-TB): MDR, XDR and the Shorter BPaLM Treatment
Drug-resistant TB (DR-TB) is TB caused by bacteria that the main TB medicines can no longer kill. Normal TB can be cured in about six months with cheap, common drugs. When the bacteria resist rifampicin (the most powerful first-line drug), treatment becomes longer, costlier and harder. This often happens when patients stop medicines midway or get poor-quality treatment.
The 94% success rate applies only to drug-susceptible TB. Drug-resistant TB has a much lower cure rate and a big treatment gap, which is why the Ministry named it as a key challenge. Shorter regimens like BPaLM are India's main answer to this problem.
- India's TB death rate: 28 per lakh (2015) to 18 per lakh (2025), a fall of 38%; global fall: 35%
- TB-related deaths in India: about 2.63 lakh in 2025, compared with just over 3 lakh in 2024
- TB cases notified in India: about 25.3 lakh in 2025
- Treatment success rate, drug-susceptible TB: 94% in India; 90% globally
- TB Mukt Bharat Abhiyaan (7 December 2024 to 8 November 2026): over 25 crore screened, over 11 crore chest X-rays, 48.64 lakh cases found, 14.97 lakh asymptomatic
- India: about one-quarter of the world's TB cases, the highest of any country
- World (2025): about 10.6 million new cases, about 1.13 million deaths
- Global RR-TB: about 3.7 lakh new cases in 2025; only about 42% treated
- WHO's revised estimates used India's Sample Registration System (SRS) data for 2022–2024; India's updated incidence estimates are expected after review of the 2025 national TB prevalence survey by ICMR-NIRT
- End TB Strategy 2025 milestone: 75% fewer deaths than 2015